Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Cardio Diagnostics Holdings, Inc. (CDIO)

Cardio Diagnostics discloses August 2026 investor presentation, no financial results

Neutral Impact 2 of 5 other Written later

Cardio Diagnostics Holdings (NASDAQ: CDIO) filed an 8-K stating that from August 20, 2026, senior management will use an August 2026 investor presentation with existing and prospective investors, and that it will be posted on the company's website. The presentation covers reimbursement milestones, lab operations and market opportunity, but the filing itself reports no revenue, earnings, or guidance, and the company states it is not providing guidance.

Key points

  • Investor presentation (Exhibit 99.1) to be used from August 20, 2026, and posted at www.cdio.ai
  • Presentation states the Company is not making projections or providing guidance on future results
  • Reimbursement: CMS final payment rate of $854 per test set December 2025; Medicare coverage determination in progress
  • Presentation cites an internal estimate of about $125 billion total addressable US market for Epi+Gen CHD and about $51 billion for PrecisionCHD, and notes market opportunity reflects potential, not current revenue

The filing

CompanyCardio Diagnostics Holdings, Inc. (CDIO)
Form8-K, current report
Filed with the SECAug 20, 2026, 8:03 AM ET
Accession number0001079973-26-001153

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 20, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.